Zions Bancorporation, National Association’s Alnylam Pharmaceuticals ALNY Stock Holding History

Zions Bancorporation, National Association’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Sell	1,159 -2,481	-68%	-$748K	0.02%	302
2026 Q1	$1.2M	Buy	3,640 +3,493	+2,376%	+$1.19M	0.08%	143
2025 Q4	$58.5K	Buy	147 +138	+1,533%	+$61.1K	﹤0.01%	576
2025 Q3	$4.1K	Sell	9 -637	-99%	-$259K	﹤0.01%	758
2025 Q2	$211K	Hold	646	–	–	0.01%	338
2025 Q1	$174K	Buy	+646	New	+$166K	0.01%	339

Other funds holding ALNY

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Zions Bancorporation, National Association's ALNY Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Alnylam Pharmaceuticals (ALNY) stake by 68% in Q2 2026, selling an estimated $748K and leaving 1,159 shares worth $349K. The position accounts for 0.02% of the portfolio, ranked #302.

Zions Bancorporation, National Association first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.2M in Q1 2026. 328 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Zions Bancorporation, National Association held 1,159 shares of Alnylam Pharmaceuticals worth $349K as of Q2 2026.
Zions Bancorporation, National Association sold 2,481 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $748K.
Alnylam Pharmaceuticals made up 0.02% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #302 holding.
Zions Bancorporation, National Association first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Zions Bancorporation, National Association's Alnylam Pharmaceuticals position peaked at $1.2M in Q1 2026.
328 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.